132 related articles for article (PubMed ID: 33351336)
1. [Radioiodine therapy outcome in toxic multinodular goiter patient with concomitant hereditary Hasharon hemoglobinopathy].
Dzeytova DS; Shklyaev SS; Rumyantsev PO; Sheremeta MS; Trukhin AA; Tsvetaeva NV; Kozhedub EE
Probl Endokrinol (Mosk); 2020 Sep; 66(3):27-32. PubMed ID: 33351336
[TBL] [Abstract][Full Text] [Related]
2. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
5. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
8. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm.
Schiavo M; Bagnara MC; Camerieri L; Pomposelli E; Giusti M; Pesce G; Reitano C; Caputo M; Bagnasco M
Endocrine; 2015 Apr; 48(3):902-8. PubMed ID: 25151403
[TBL] [Abstract][Full Text] [Related]
10. The significance of serum thyroglobulin measurement before and after the treatment of toxic nodular goiter with 131I.
Bonefačić B; Crnčić TB; Tomaš MI; Girotto N; Ivanković SG
Nucl Med Commun; 2020 Apr; 41(4):344-349. PubMed ID: 31977753
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
[TBL] [Abstract][Full Text] [Related]
12. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
Jedrzejuk D; Milewicz A
Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of multinodular non-toxic goitre.
Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
[TBL] [Abstract][Full Text] [Related]
14. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
15. Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter.
Peterson ME
J Endocrinol; 2014 Nov; 223(2):T97-114. PubMed ID: 25297557
[TBL] [Abstract][Full Text] [Related]
16. Concomitant hyperthyroidism in patients with thyroid carcinoma and the effects of iodine supplementation in an iodine-deficient area.
Omür O; Yazc B; Akgün A; Ozcan Z; Akyldz M; Argon M; Ozklç H
Clin Nucl Med; 2008 Nov; 33(11):769-72. PubMed ID: 18936609
[TBL] [Abstract][Full Text] [Related]
17. [Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].
Dietlein M; Dederichs B; Kobe C; Theissen P; Schmidt M; Schicha H
Nuklearmedizin; 2006; 45(1):21-34; quiz N1-2. PubMed ID: 16493511
[TBL] [Abstract][Full Text] [Related]
18. Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
Mizokami T; Hamada K; Maruta T; Higashi K; Tajiri J
Endocr J; 2021 Sep; 68(9):1117-1125. PubMed ID: 33980774
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
